Biocad To Launch Two Biosimilars In Bosnia-Herzegovina
Forms Part Of Russian Firm's Plans For European Expansion
Executive Summary
Russia’s Biocad, with biosimilars already launched in numerous global markets, is continuing to look outward. A focus on territories in south-east Europe has seen the firm receive approvals for two biosimilars in the Balkan country Bosnia and Herzegovina.